Navigation Links
Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings
Date:12/3/2008

EMERYVILLE, Calif., Dec. 3 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI) today announced that the FDA has reviewed the company's manufacturing and control process descriptions (CMC), and has provided guidance on how Bionovo can move forward with the development of Menerba (formerly named MF101) for menopausal hot flashes.

"We have concluded three CMC discussions with the FDA, and are moving to address the Agency's recommendations for further development of Menerba. The recommendations with respect to the analytical characterization were made by the Pre-Marketing division of the Agency, in order to ensure continuous drug consistency. There are some areas of the drug development process requiring further discussion on how to best implement the Agency's Guidance for Industry for Botanical Drug Products. Bionovo will be moving with all possible diligence to reach agreement on these areas with the FDA. We will start manufacturing the clinical material using the commercial process immediately. During these discussions no concerns were expressed about either the safety nor the efficacy of Menerba," said Dr. Isaac Cohen, Bionovo's Chairman and CEO.

Bionovo completed a multicenter Phase 2, double-blind, placebo-controlled randomized clinical trial evaluating Menerba for the treatment of hot flashes in 217 healthy post-menopausal women enrolled at 6 clinical sites in the U.S. The principal investigator of the trial was Dr. Deborah Grady from the University of California, San Francisco. Menerba showed a statistically significant reduction in the number of hot flashes after 12 weeks of treatment (-62%, p=0.05) and had a statistically significant reduction in nighttime awakenings from hot flashes (-67%, p=0.05). There was no difference in uterine bleeding between treatment groups and placebo, and no uterine abno
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Bionovo Announces Positive Developments in On-going Phase 1/2 Cancer Drug Trial
2. Bionovo Announces Publication of the Paper Detailing the Mechanism of Action of Its Cancer Drug BZL101
3. Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs
4. Bionovos Drug Candidate for Menopausal Symptoms Shows Effect on Neural Pathways Related to Temperature Regulation
5. Bionovo Elucidates Mechanism of Breast Cancer Control by Estrogen Receptor Beta
6. Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate
7. Bionovos MF101 Shows Statistically Significant Improvement in Sleep Disturbance from Hot Flashes
8. Bionovos VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness
9. Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer
10. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
11. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... -- GenVec, Inc. (NASDAQ: GNVC ) today announced a ... and his team from the School of Medicine at ... (WUSTL).  Dr. Curiel is the director of the Biologic ... Department of Radiation Oncology. Under the ... versions of GenVec,s gorilla adenovectors that incorporate specialized targeting ...
(Date:6/3/2015)... June 3, 2015  Armetheon, Inc., a specialty ... cardiovascular diseases, today announced that Sanjay Kakkar ... Executive Officer, effective immediately. Dr. Kakkar brings more ... enterprises, with a successful track record in advancing ... With expertise that includes the development of novel ...
(Date:6/3/2015)... June 02, 2015 Research and Markets ( ... "Europe CT Market - Growth, Trends And Forecasts (2014 ... Computed tomography (CT) is an imaging process that customs ... images, or scans, of areas inside the body. It ... (CAT) scanning. It is primarily used in the Cancer ...
Breaking Medicine Technology:GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines 2GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines 3GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines 4Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 2Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 3Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 4Europe CT Market Report 2015-2019 - Growth, Trends And Forecasts 2
... July 1 Caraco Pharmaceutical Laboratories, Ltd. (NYSE ... capsules. These products, approved by the US Food and ... Application (ANDA), are therapeutically equivalent to Exelon® capsules from ... to moderate Alzheimer,s dementia and mild to moderate Parkinson,s ...
... BEIJING , July 1 /PRNewswire-Asia-FirstCall/ ... the development, assembly, marketing and,sale of medical devices and homecare medical products ... Financial Officer, and Sam Shuguang Gui, Vice,President of Strategic Development, will present ... San Francisco, CA. , , ...
Cached Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Exelon® Capsules 2Dehaier Medical Systems to Present to Investors at Global Hunter Securities 2010 China Investor Conference in San Francisco 2Dehaier Medical Systems to Present to Investors at Global Hunter Securities 2010 China Investor Conference in San Francisco 3
(Date:6/3/2015)... (PRWEB) June 03, 2015 Peter Piot, ... Award at DIA’s upcoming Annual Meeting. DIA’s Global Inspire ... leadership, level of excellence, and commitment to service on ... the President’s Award for Outstanding Contribution to Global Health ... contributions to advancing global health. , “DIA ...
(Date:6/3/2015)... FL (PRWEB) June 03, 2015 For the ... LLC, ( http://myclassifiedads.net ), a full-service advertising agency, has been ... Tampa Chamber of Commerce. , MCA has been selected as ... Awards. The company will be honored at a luncheon sponsored ... at the Tampa Museum of Art. , “This luncheon will ...
(Date:6/3/2015)... Fourroux Prosthetics, located at 6630 McGinnis Ferry Rd, ... opening with a ribbon cutting ceremony on Wednesday, June ... kind in the area, Fourroux Prosthetics will provide amputee ... use of patented advanced prosthetics CAD/CAM technology. ... states, “Our goal has always been to provide amputees ...
(Date:6/3/2015)... Scanalytics ” was featured on NewsWatch as part of ... coolest technology products available to consumers. Andrew Tropeano, a ... review and shared with viewers how this technology allows ... Tracking statistics in business is invaluable in analyzing and ... goes a step beyond revenue statistics and tracking how ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 Veatch Consulting ... Satisfaction. Since they first opened for business in April ... service the needs of their clients. Each and every ... Veatch Dental Consulting is proud to say that they ... , A new feature recently added this year is ...
Breaking Medicine News(10 mins):Health News:Co-discoverer of Ebola Virus and AIDS Pioneer to be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 2Health News:Co-discoverer of Ebola Virus and AIDS Pioneer to be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 3Health News:My Classified Ads Has Been Selected as a Semi-Finalist for the 2015 ‘Small Business of the Year’ Awards 2Health News:My Classified Ads Has Been Selected as a Semi-Finalist for the 2015 ‘Small Business of the Year’ Awards 3Health News:Fourroux Prosthetics Atlanta to Have Grand Opening Gala & Ribbon Cutting Ceremony 2Health News:Technology to Analyze Foot Traffic in Retail Stores was featured on NewsWatch Television 2Health News:Veatch Consulting Services Is Breaking New Ground in Customer Satisfaction 2Health News:Veatch Consulting Services Is Breaking New Ground in Customer Satisfaction 3
... two thirds of the Britons fearing heart attacks are willing ... reluctance in calling emergency help have proved to be fatal ... biggest killer, often killing at least one in every five ... was conducted under the BHF's 'Doubt Kills' campaign aiming at ...
... is used to treat bleeding disorders, like hemophilia, is being ... Iraq. // ,The drug Recombinant Activated Factor VIII has ... non-hemophiliacs. It can cause heart attacks, and strokes due to ... effects, continue to prescribe it to control life threatening blood ...
... Southwester Medical Center, children who were treated successfully for leukemia ... in life. // ,In addition, childhood cancer survivors who ... cancer showed even greater risk of stroke in later life, ... issue of the Journal of Clinical Oncology and is available ...
... studies have dug out evidence that link cancer to ... the studies conducted by scientists from University of California, ... have lesser chances of contracting ovarian cancer. Their study, ... that more exposure of sunlight will result in more ...
... of Norovirus has been reported in Royal Bournemouth Hospital. The ... 4,5,27 // and 28 to visitors. Hospital authorities have confirmed ... It does not pose any threat to other departments especially ... of kin are permitted to visit patients in the hospital ...
... near, the hunt is on for parents to find the ... toys and games are available, Anne Mejia Downs // , ... urges parents to look specifically for toys and games that ... the country, toys that get kids moving are some of ...
Cached Medicine News:Health News:Childhood Survivors Of Brain Tumors More At Risk For Strokes Later In Life 2Health News:Childhood Survivors Of Brain Tumors More At Risk For Strokes Later In Life 3Health News:Buy Children Holiday Gifts That Encourage Physical Activity 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: